cilazapril, anhydrous has been researched along with Cardiac Failure in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.29) | 18.7374 |
| 1990's | 16 (57.14) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwao, H; Kim, S; Nakao, T; Namba, M; Zhan, Y | 1 |
| Gocer, H; Tavli, T | 2 |
| Kurita, A; Takase, B | 1 |
| Ari, Z; Goktalay, T; Sekuri, C; Tavli, T; Uyanik, BS | 1 |
| Arabatzis, N; Dössegger, L; Nielsen, T; Preston, C | 1 |
| Clozel, JP; Clozel, M; Hess, P; Löffler, BM; Maire, JP; Teerlink, JR | 1 |
| Corder, CN; Deere, LF; Harwood, W; Nagarajan, R; Peguero-Rivera, A; Puls, A; Rubler, S | 1 |
| Cassel, W; Mayer, J; Peter, JH; Ploch, T; von Wichert, P; Weichler, U | 1 |
| Reisin, L | 1 |
| Berger, PB; Faxon, DP; Holmes, DR; Murphy, JG; O'Hanesian, MA; Ohman, EM; Schwartz, RS; Serruys, PW | 1 |
| Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T | 1 |
| Bosma, AH; Dössegger, L; Glogar, D; Jensen, G; Larsen, J; Moccetti, T; Schelling, A; Sykulski, R; Trimarco, B | 1 |
| Mulder, P; Richard, V; Thuillez, C | 1 |
| Bulpitt, CJ; Dössegger, L; Fletcher, AE; Neiss, A; Nielsen, T; Viergutz, S | 1 |
| Cooke, GA; Tan, LB; Williams, SG; Wright, DJ | 1 |
| Hayashidani, S; Ide, T; Kinugawa, S; Suematsu, N; Takeshita, A; Tsutsui, H; Utsumi, H | 1 |
| Hazama, K; Momma, K; Nakazawa, M | 1 |
| Brown, AN; Dymond, DS; Elstob, JE; Francis, RJ; Rajaguru, S; Steiner, J; Wiseman, MN | 1 |
| Burkart, F; Elsasser, S; Erne, P; Kiowski, W; Pfisterer, M; Zuber, M | 1 |
| Burkart, F; Drexler, H; Just, H; Kiowski, W; Meinertz, T; Ritz, R; Zuber, M | 1 |
| Brogden, RN; Deget, F | 1 |
| Banhardt, U; Drexler, H; Just, H; Lehmann, M; Meinertz, T; Wollschläger, H | 1 |
| Clozel, JP | 1 |
| Brown, AN; Curry, PV; Francis, RJ; Rajaguru, S; Rosenthal, E; Steiner, J; Williams, PE | 1 |
| Burkart, F; Kiowski, W | 1 |
3 review(s) available for cilazapril, anhydrous and Cardiac Failure
| Article | Year |
|---|---|
Heart failure therapy with cilazapril: an overview.
Topics: Cardiomyopathy, Dilated; Cilazapril; Digitalis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardial Ischemia; Plants, Medicinal; Plants, Toxic | 1994 |
Disparate results of ACE inhibitor dosage on exercise capacity in heart failure: a reappraisal of vasodilator therapy and study design.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Enalapril; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Lisinopril; Prognosis; Research Design; Vasodilator Agents | 2001 |
Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Drug Interactions; Heart Failure; Humans; Hypertension; Pyridazines | 1991 |
12 trial(s) available for cilazapril, anhydrous and Cardiac Failure
| Article | Year |
|---|---|
The acute effects of cilazapril on pulmonary function tests and arterial blood gas changes in patients with pulmonary hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Gas Analysis; Blood Pressure; Cilazapril; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Oxygen; Pulmonary Gas Exchange; Stroke Volume | 2003 |
Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Chronic Disease; Cilazapril; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged | 1995 |
Heart failure therapy with cilazapril: an overview.
Topics: Cardiomyopathy, Dilated; Cilazapril; Digitalis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardial Ischemia; Plants, Medicinal; Plants, Toxic | 1994 |
Effect of cilazapril on exercise tolerance in congestive heart failure.
Topics: Aged; Anaerobic Threshold; Cilazapril; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption | 1993 |
[Does placebo lower nocturnal blood pressure in sleep-related respiratory disorders and arterial hypertension?].
Topics: Adult; Aged; Blood Pressure; Cilazapril; Double-Blind Method; Heart Failure; Humans; Hypertension; Male; Middle Aged; Placebo Effect; Sleep Apnea Syndromes | 1993 |
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Cilazapril; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Statistics, Nonparametric; Treatment Outcome | 1996 |
Adaptive changes in the acute haemodynamic effects of cilazapril during chronic treatment. Comparison with long-term clinical effect.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1996 |
Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cilazapril; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life | 1998 |
Effective dose and cardiovascular effects of cilazapril in children with heart failure.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cilazapril; Female; Heart Failure; Hemodynamics; Humans; Infant; Male; Treatment Outcome | 2001 |
Cilazapril in congestive heart failure. A pilot study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Pyridazines | 1991 |
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Leg; Male; Middle Aged; Muscles; Oxygen Consumption; Pyridazines; Random Allocation; Regional Blood Flow; Time Factors | 1989 |
A pharmacokinetic study of cilazapril in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Capsules; Cilazapril; Female; Gelatin; Heart Failure; Hippurates; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pyridazines | 1989 |
14 other study(ies) available for cilazapril, anhydrous and Cardiac Failure
| Article | Year |
|---|---|
Combination treatment with a calcium channel blocker and an angiotensin blocker in a rat systolic heart failure model with hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Cilazapril; Dihydropyridines; Drug Therapy, Combination; Heart Failure; Hypertension; Kidney; Natriuretic Peptide, Brain; Organ Size; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Survival Rate; Systole; Transforming Growth Factor beta | 2002 |
Effects of cilazapril on endothelial function and pulmonary hypertension in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Brachial Artery; Cilazapril; Coronary Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hypertension, Pulmonary; Male; Middle Aged; Vasodilation | 2002 |
The effects of handgrip stress test on hemodynamic parameters before and after cilazapril treatment in patients with heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Echocardiography, Doppler; Exercise Test; Female; Hand Strength; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 2003 |
Efficacy of handgrip stress test for evaluation of cilasapril treatment in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Confounding Factors, Epidemiologic; Evaluation Studies as Topic; Hand Strength; Heart Failure; Humans | 2003 |
A vascular protective concept in hypertension and heart failure. Proceedings of the 4th International Symposium on Cilazapril. Istanbul, Turkey, November 25-27, 1993.
Topics: Animals; Cilazapril; Heart Failure; Humans; Hypertension | 1994 |
Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Topics: Animals; Blood Pressure; Bosentan; Chronic Disease; Cilazapril; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Male; Rats; Rats, Wistar; Sulfonamides | 1994 |
[Angiotensin converting enzyme inhibitor-induced cough: patterns and incidence. Consequences for continuation of therapy].
Topics: Aged; Captopril; Cilazapril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Long-Term Care; Male; Middle Aged | 1993 |
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume | 1995 |
Different effects of calcium antagonists in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Calcium Channel Blockers; Catecholamines; Chronic Disease; Cilazapril; Heart Failure; Heart Ventricles; Hemodynamics; Male; Mibefradil; Myocardial Contraction; Random Allocation; Rats; Rats, Wistar; Renin; Survival Rate; Tetrahydronaphthalenes | 1998 |
Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Electron Spin Resonance Spectroscopy; Heart Failure; Hypertrophy, Left Ventricular; Male; Oxidative Stress; Piperidines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium Chloride, Dietary; Survival Rate; Ventricular Dysfunction, Left | 2001 |
Initial and steady state pharmacokinetics of cilazapril in congestive cardiac failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Female; Heart Failure; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pyridazines | 1991 |
Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Coronary Vessels; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Male; Myocardium; Neurotransmitter Agents; Pyridazines; Time Factors; Vasodilation | 1991 |
Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Cilazapril; Heart Failure; Hemodynamics; Myocardial Infarction; Myocardium; Pyridazines; Rats; Rats, Inbred Strains; Vascular Resistance | 1989 |
Effects of vasodilators on the coronary circulation in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Coronary Circulation; Heart Failure; Humans; Hydralazine; Nitroglycerin; Prazosin; Pyridazines; Vasodilator Agents | 1988 |